Suppr超能文献

与沙利度胺相伴:40岁时的健康状况和生活质量

Living with thalidomide: health status and quality of life at 40 years.

作者信息

Bent N, Tennant A, Neumann V, Chamberlain M A

机构信息

Academic Unit of Musculoskeletal and Rehabilitation Medicine, University of Leeds, UK.

出版信息

Prosthet Orthot Int. 2007 Jun;31(2):147-56. doi: 10.1080/03093640600988567.

Abstract

Thalidomide was first synthesized in 1953 and was subsequently marketed as a mild hypnotic and sedative in more than 20 countries. By 2001 it was estimated that there were 5,000 survivors from the 10,000 - 12,000 babies who were, as a result, born with severe abnormalities. For these survivors, recent concerns have emerged about their physical state, in particular their levels of pain and their ability to maintain independence. It was therefore wished to ascertain health status and current concerns amongst a sample of survivors living in the UK. A combination of qualitative and quantitative methodologies was employed. Qualitative interviews were undertaken with a sample drawn from the population affected by thalidomide known to the Thalidomide Trust. Selection of participants was based upon a theoretical sample frame. Postal questionnaires to examine health status and various psychosocial aspects concerned with living with the consequences of thalidomide were sent subsequently to these same participants and to a random sample of those not originally drawn for the qualitative interviews. For the qualitative interviews, 28 agreed to take part; two refused and the remainder did not respond. Those agreeing to interview were representative of the original compensation bands (Chi-Square = 3.929; p = 0.416). Several themes emerged from these interviews, including the effects on work and career; coping in terms of attitude to life, self-image, confidence, self-esteem, stress and emotion; relationships, independent living issues and emergent problems such as pain, quality of life, and anxiety about the future. A postal questionnaire was then sent to those who had agreed to interview (28), plus a random sample of the remaining group who were not initially chosen for the qualitative interviews. In total 82 people were sent the questionnaire, of whom 41 (50%) responded. Two-thirds of responders were female. Seven out of ten lived with a partner, and over half (56%) had children. Almost half (46%) were in work, but 32% reported they were permanently unable to work because of disability. Current levels of impairment were found to be similar across groups defined by the original compensation band. In contrast, the activity limitation measures showed a steep gradient across bands but only 37% considered themselves disabled. Nevertheless, despite the restriction in activities for some, levels of participation were similar across bands; likewise simple summary items on health status and quality of life were similar and 70% reported their quality of life (QoL) was good or better than good. Yet nine in ten believed that their body was less flexible than in the past. Almost as many reported they were less able to carry things. It turns out that when compensation bands were grouped (1 - 3, 4 - 5) to highlight those most severely affected according to the original assessment, then those in the higher band grouping reported significantly more musculoskeletal problems, high levels of fatigue and increasing dependency and feelings of vulnerability. It is clear that the original ranking of disability severity, as expressed through the compensation, bands (allocated in early childhood in most cases), is consistent with current ranking of limitations in activity and participation. Nevertheless, despite high levels of disability amongst some survivors, lifelong adjustments to the original impairments have resulted in more than two thirds reporting at least a good quality of life. However, survivors expressed increasing concern about emerging musculoskeletal and other problems which may compromise hard-won independence.

摘要

沙利度胺于1953年首次合成,随后在20多个国家作为一种温和的催眠镇静剂上市销售。到2001年,据估计,在10000至12000名因此而出生时患有严重畸形的婴儿中,有5000名幸存者。对于这些幸存者,最近人们开始关注他们的身体状况,特别是他们的疼痛程度以及维持独立生活的能力。因此,希望了解居住在英国的一部分幸存者的健康状况和当前所关心的问题。研究采用了定性和定量相结合的方法。对从沙利度胺信托基金所了解的受沙利度胺影响人群中抽取的样本进行了定性访谈。参与者的选择基于理论样本框架。随后向这些参与者以及未被最初选入定性访谈的随机样本发送了邮政问卷,以调查健康状况以及与沙利度胺后遗症相关的各种心理社会方面的情况。对于定性访谈,28人同意参与;2人拒绝,其余未回复。同意接受访谈的人代表了最初的赔偿等级(卡方 = 3.929;p = 0.416)。这些访谈中出现了几个主题,包括对工作和职业的影响;在生活态度、自我形象、信心、自尊、压力和情绪方面的应对;人际关系、独立生活问题以及新出现的问题,如疼痛、生活质量和对未来的焦虑。然后向同意接受访谈的人(28人)以及最初未被选入定性访谈的其余人群的随机样本发送了邮政问卷。总共向82人发送了问卷,其中41人(50%)回复。三分之二的回复者为女性。十分之七的人与伴侣同住,超过一半(56%)育有子女。几乎一半(46%)有工作,但32%报告称由于残疾他们永久无法工作。发现当前的损伤程度在由最初赔偿等级定义的各组中相似。相比之下,活动受限措施在各等级之间呈现出陡峭的梯度,但只有37%的人认为自己有残疾。然而,尽管一些人在活动方面受到限制,但各等级之间的参与程度相似;同样,关于健康状况和生活质量的简单汇总项目也相似,70%的人报告他们的生活质量(QoL)良好或优于良好。然而,十分之九的人认为他们的身体比过去更不灵活。几乎同样多的人报告称他们搬运东西的能力下降。结果发现,当根据最初评估将赔偿等级分组(1 - 3、4 - 5)以突出那些受影响最严重的人时,处于较高等级分组的人报告的肌肉骨骼问题、高水平的疲劳以及越来越强的依赖性和脆弱感明显更多。很明显,通过赔偿等级(大多数情况下在幼儿期分配)所体现的最初残疾严重程度排名与当前活动和参与受限的排名是一致的。然而,尽管一些幸存者存在高度残疾,但对最初损伤的终身调整使得超过三分之二的人报告至少有良好的生活质量。然而,幸存者对新出现的肌肉骨骼和其他可能损害来之不易的独立性的问题表示越来越担忧。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验